Robert Narquizian

926 total citations
18 papers, 475 citations indexed

About

Robert Narquizian is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Robert Narquizian has authored 18 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Organic Chemistry. Recurrent topics in Robert Narquizian's work include Beetle Biology and Toxicology Studies (5 papers), Diabetes Treatment and Management (4 papers) and Neuropeptides and Animal Physiology (4 papers). Robert Narquizian is often cited by papers focused on Beetle Biology and Toxicology Studies (5 papers), Diabetes Treatment and Management (4 papers) and Neuropeptides and Animal Physiology (4 papers). Robert Narquizian collaborates with scholars based in Switzerland, United Kingdom and United States. Robert Narquizian's co-authors include Philip Kocieński, Christopher R. Smith, Piotr Raubo, Helmut Jacobsen, Holger Fischer, Hans Hilpert, Michael Hennig, Bernd Kuhn, Patrizio Mattei and Laurence Ozmen and has published in prestigious journals such as Journal of Neuroscience, Journal of Medicinal Chemistry and Chemistry - A European Journal.

In The Last Decade

Robert Narquizian

17 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Narquizian Switzerland 14 200 172 91 86 81 18 475
Laura Scalvini Italy 14 322 1.6× 138 0.8× 79 0.9× 190 2.2× 30 0.4× 41 708
Ranju Kumari India 13 293 1.5× 136 0.8× 101 1.1× 57 0.7× 45 0.6× 22 537
Brian A. McKittrick United States 16 306 1.5× 396 2.3× 56 0.6× 101 1.2× 54 0.7× 43 714
Gabriella Ortore Italy 19 517 2.6× 243 1.4× 136 1.5× 165 1.9× 41 0.5× 53 792
Mark A. Sanner United States 13 217 1.1× 446 2.6× 118 1.3× 78 0.9× 65 0.8× 21 758
Marlys Hammond United States 15 384 1.9× 426 2.5× 53 0.6× 67 0.8× 20 0.2× 24 778
Fabienne Dulin France 10 169 0.8× 86 0.5× 64 0.7× 28 0.3× 89 1.1× 12 430
Giulia Nesi Italy 12 218 1.1× 110 0.6× 29 0.3× 57 0.7× 92 1.1× 16 550
Erik A. A. Wallén Finland 20 450 2.3× 437 2.5× 231 2.5× 143 1.7× 33 0.4× 46 1.1k
Jun Terauchi Japan 10 241 1.2× 199 1.2× 70 0.8× 90 1.0× 135 1.7× 18 621

Countries citing papers authored by Robert Narquizian

Since Specialization
Citations

This map shows the geographic impact of Robert Narquizian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Narquizian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Narquizian more than expected).

Fields of papers citing papers by Robert Narquizian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Narquizian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Narquizian. The network helps show where Robert Narquizian may publish in the future.

Co-authorship network of co-authors of Robert Narquizian

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Narquizian. A scholar is included among the top collaborators of Robert Narquizian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Narquizian. Robert Narquizian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jacobsen, Helmut, Laurence Ozmen, Antonello Caruso, et al.. (2014). Combined Treatment with a BACE Inhibitor and Anti-Aβ Antibody Gantenerumab Enhances Amyloid Reduction in APPLondonMice. Journal of Neuroscience. 34(35). 11621–11630. 68 indexed citations
2.
Woltering, Thomas J., Wolfgang Wostl, Hans Hilpert, et al.. (2013). BACE1 inhibitors: A head group scan on a series of amides. Bioorganic & Medicinal Chemistry Letters. 23(14). 4239–4243. 43 indexed citations
3.
Kratochwil, Nicole A., Marius C. Hoener, Lothar Lindemann, et al.. (2011). G Protein-Coupled Receptor Transmembrane Binding Pockets and their Applications in GPCR Research and Drug Discovery: A Survey. Current Topics in Medicinal Chemistry. 11(15). 1902–1924. 17 indexed citations
4.
Peters, Jens‐Uwe, Henrietta Dehmlow, Uwe Grether, et al.. (2010). Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: Optimization of in vitro activity. Bioorganic & Medicinal Chemistry Letters. 20(18). 5426–5430. 11 indexed citations
5.
Mattei, Patrizio, Markus Boehringer, Holger Fischer, et al.. (2009). Discovery of carmegliptin: A potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry Letters. 20(3). 1109–1113. 54 indexed citations
6.
Boehringer, Markus, Holger Fischer, Michael Hennig, et al.. (2009). Aryl- and heteroaryl-substituted aminobenzo[a]quinolizines as dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(3). 1106–1108. 38 indexed citations
7.
Pinard, Emmanuel, Daniela Alberati, Edilio Borroni, et al.. (2008). Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(18). 5134–5139. 18 indexed citations
8.
Jolidon, Synèse, Daniela Alberati, Adam Dowle, et al.. (2008). Design, synthesis and structure–activity relationship of simple bis-amides as potent inhibitors of GlyT1. Bioorganic & Medicinal Chemistry Letters. 18(20). 5533–5536. 15 indexed citations
9.
Lübbers, Thomas, Luca Gobbi, Michael Hennig, et al.. (2007). 1,3-Disubstituted 4-aminopiperidines as useful tools in the optimization of the 2-aminobenzo[a]quinolizine dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(11). 2966–2970. 30 indexed citations
10.
Morton, Daniel, et al.. (2007). Desymmetrisation of a Centrosymmetric Molecule by Carbon–Carbon Bond Formation: Asymmetric Aldol Reactions of a Centrosymmetric Dialdehyde. Chemistry - A European Journal. 13(20). 5857–5861. 6 indexed citations
11.
Russell, Michael G. N., Robert W. Carling, John Atack, et al.. (2005). Discovery of Functionally Selective 7,8,9,10-Tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABAAReceptor Agonists at the α3Subunit. Journal of Medicinal Chemistry. 48(5). 1367–1383. 54 indexed citations
12.
Atack, John, Peter Blurton, Robert W. Carling, et al.. (2004). 2,5-Dihydropyrazolo[4,3-c]pyridin-3-ones: functionally selective benzodiazepine binding site ligands on the GABAA receptor. Bioorganic & Medicinal Chemistry Letters. 14(13). 3441–3444. 18 indexed citations
13.
14.
Narquizian, Robert & Philip Kocieński. (2000). The Pederin Family of Antitumor Agents: Structures, Synthesis and Biological Activity. PubMed. 25–56. 32 indexed citations
15.
Kocieński, Philip, Robert Narquizian, Piotr Raubo, et al.. (2000). Synthetic studies on the pederin family of antitumour agents. Syntheses of mycalamide B, theopederin D and pederin. Journal of the Chemical Society Perkin Transactions 1. 2357–2384. 36 indexed citations
16.
Kocieński, Philip, et al.. (1998). A Synthesis of Theopederin D and a Formal Synthesis of Pederin. Synlett. 1998(12). 1432–1434. 15 indexed citations
17.
Kocieński, Philip, et al.. (1998). ChemInform Abstract: A Synthesis of Mycalamide B.. ChemInform. 29(47). 1 indexed citations
18.
Kocieński, Philip, et al.. (1998). A Synthesis of Mycalamide B. Synlett. 1998(8). 869–872. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Scalvini Breakdown of academic impact, for papers by Ranju Kumari Breakdown of academic impact, for papers by Brian A. McKittrick Breakdown of academic impact, for papers by Gabriella Ortore Breakdown of academic impact, for papers by Mark A. Sanner Breakdown of academic impact, for papers by Marlys Hammond Breakdown of academic impact, for papers by Fabienne Dulin Breakdown of academic impact, for papers by Giulia Nesi Breakdown of academic impact, for papers by Erik A. A. Wallén Breakdown of academic impact, for papers by Jun Terauchi
Rankless by CCL
2026